Le Lézard
Classified in: Health
Subject: PLW

Puritan Rejects Competitor's Patent Infringement Claim


Company confident that COPAN complaint is without merit and will vigorously defend its product rights

GUILFORD, Maine, June 11, 2018 /PRNewswire/ -- Puritan Medical Products Co., LLC?an American company with a worldwide reputation as a trusted manufacturer of swabs and single-use specimen collection devices?announced today that it unequivocally rejects a complaint alleging unfair competition and patent infringement filed by COPAN Italia S.p.A. and its U.S. subsidiary, COPAN Diagnostics Inc., in federal district court in Maine.

"We were surprised and highly disappointed by this action," said Terry Young, Puritan's General Manager & COO. "We are currently reviewing this unexpected complaint and preparing our response and potential counterclaims. Puritan is confident in its position and will continue routine operations to manufacture and supply all customers with its patented Puritan flock swab products."

Puritan has been producing quality medical products for nearly 100 years and currently holds 14 international patents for its flocked swab products.

"We have always competed fairly and ethically in the marketplace. We strongly believe that this claim is without merit and will vigorously defend our product rights," Young stated.

About Puritan

Puritan Medical Products Co., LLC, is an American company known worldwide as the trusted manufacturer of single-use products for the healthcare, diagnostic, forensic, critical environment, food safety, and drug manufacturing industries. Puritan manufactures all of its flocked swab products in their Guilford, ME, U.S. facility.

For More Information Contact
Timothy Templet
Executive VP of Global Sales
[email protected]
+1.207.876.3311

Logo - https://mma.prnewswire.com/media/703607/Puritan_Medical_Logo.jpg


These press releases may also interest you

at 07:50
Algernon Pharmaceuticals Inc. (the "Company" or "AGN Pharma") , a Canadian clinical stage pharmaceutical development company, is pleased to announce that its subsidiary Algernon NeuroScience (AGN Neuro), along with the Centre for Human Drug...

at 07:35
Endeavor BioMedicines, Inc. ("Endeavor"), a clinical-stage biotechnology company developing medicines with the potential to deliver transformational clinical benefits to patients with life-threatening diseases, today announced the closing of a $132.5...

at 07:30
BioArctic AB's (publ) partner Eisai today published the preliminary global revenue for Leqembi during the first quarter 2024, in conjunction with their partner Biogen's first quarter report. In total, sales of JPY 2.83 billion were recorded in the...

at 07:25
RxLightning, creator of the industry's leading platform for streamlining specialty medication access and affordability, is proud to have reached a number of meaningful milestones in the last year ? including significant increases in provider users,...

at 07:12
Highlights from Chiesi Group's 2023 financial report: Sales increased to over ?3 billion, up 10% compared to 2022 (+12% @CER), driven by the Rare business unit growth (65% @CER), and steady growth of all products in all its Regions24% of 2023 sales...

at 07:05
Av?sis and Harmony Health have joined forces to bridge oral healthcare gaps for underserved Medicaid populations with special healthcare needs. The pilot aims to revolutionize preventive dentistry by harnessing the power of real-time salivary testing...



News published on and distributed by: